Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones

The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they occur, according to a new American Heart Association scientific statement, published today in the Association’s journal Circulation: Genomic and Precision Medicine.


Leave a Reply

Your email address will not be published. Required fields are marked *